(FMTX) |
| 0 (0%) 10-10 11:47 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 23.37 |
| Resistance 1: | 20.01 |
| Pivot price: | 20.01 |
| Support 1: | 19.99 |
| Support 2: | 19.98 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -3.290 |
| Book Value | 11.460 |
| PEG Ratio | 0.00 |
| Gross Profit | -2.651 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -19.5 |
| Return on Equity (ttm) | -33.6 |
Company news
Mon, 23 Dec 2024
Fecal microbiota transplants facilitate post-antibiotic recovery of gut microbiota in cheetahs ( Acinonyx jubatus - Nature
Fri, 30 Sep 2022
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease - Business Wire
Thu, 01 Sep 2022
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders - Business Wire
Thu, 03 Mar 2022
Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays - PNAS
Fri, 31 Dec 2021
Protected by a Police DIG, Cypterix Company's Muiz Ibrahim Walks Free After 'Robbing Investors of N800m' - FIJ NG
Thu, 07 Jan 2021
Forma Therapeutics Elects Renowned Doctor and Health Disparities Expert Selwyn M. Vickers, M.D., to Board of Directors - Business Wire
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
